BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Intrinsic Medical Imaging Receives 510(k) Clearance for 3-D Workstation


6/29/2012 9:08:24 AM

Bloomfield, MI (PRWEB) June 27, 2012 - Intrinsic Medical Imaging, a pioneer in trailblazing high performance 3D medical imaging software, announced it has received FDA pre-market notification clearance for its groundbreaking IMI Spectrum 3D imaging workstation (K121023). The company’s next generation 3D capabilities will provide visualization and quantification tools designed to overcome errors, inconsistencies and challenges associated with analyzing images utilizing existing conventional 2D and 3D methods.

“Intrinsic provides revolutionary, advanced 3D visualization which could enable a virtual angioscopy of the inside of cardiac structures through a simple, noninvasive CT scan,” said Arie Blitz, MD, director, Heart Transplantation and Mechanical Circulatory Support, University Hospitals Case Medical Center, Cleveland, Ohio. “For example, we processed a patient’s standard 2D CT images using the IMI technology and saw thrombi in 3D previously undetected in 2D. This is amazing technology.”

Intrinsic uses uncompressed rendering techniques that preserve the integrity of the data from 2D to 3D while enabling the user to navigate in real-time, anywhere in the volume, while mitigating visual artifacts and creating a more natural and user-friendly environment. High-performance algorithms process more than 100 times more operations per second than existing 3D solutions, generating an order-of-magnitude improvement in spatial resolution and image detail over existing standards. The IMI Spectrum 3D image visualization platform provides clinicians with diagnostic, planning and treatment solutions to enhance clinical accuracy and speed with the goal of saving lives.

"Receipt of this clearance is a significant step for our company and we look forward to improving patient outcomes while reducing unnecessary healthcare expenditures through the introduction of the IMI Spectrum later this year," said Jorey Chernett, CEO of Intrinsic Medical Imaging. “Engaging clinicians throughout the development process is core to our commercialization strategy and clinical feedback has been extremely positive on the potential of the IMI Spectrum technology. Intrinsic has attracted a highly accomplished team with deep domain expertise focused on revolutionizing 3D medical imaging.”

About Intrinsic Medical Imaging

Intrinsic Medical Imaging, based in Bloomfield Hills, Michigan, is a medical software company focused on the commercialization of novel high performance rendering techniques. The IMI Spectrum workstation built around IMI’s Authentic 3D software is an imaging system that enables the real-time processing, review and analysis of volumetric data generated by standard computed tomography scanners. For more information, visit http://www.intrinsic-mi.com.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES